Unit dosing of darbepoetin alfa for the treatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients

Current Therapeutic Research - Clinical and Experimental

Volumn 66, Issue 3, 2005, Pages 195-211

  Bristoyiannis, Georgios ^a   Germanos, Nikolaos ^b   Grekas, Dimitrios ^c   Hatzidimitriou, Christos ^d   Iatrou, Christos ^e   Memmos, Dimitrios ^f   Moutafis, Spiros ^g   Papachristoforou, Konstantinos ^h   Papadoniou, Antonis ⁱ   Pappas, Michalis ^j   Sakellariou, George A ^k   Siamopoulos, Kostas C ^l   Sombolos, Konstantinos ^m   Stamatelou, Kiriaki ⁿ   Stathakis, Charalambos P ^o   Stavgiannoudakis, Georgios ^p   Stratigis, Spiros ^q   Syrganis, Christos ^r   Tsakiris, Dimitris ^s   Valis, Dimitris ^t   Vlahojannis, Jannis G ^u   Vlassopoulos, Dimosthenis ^v   more..

^a General Prefectorial Hospital of Kalamata   (Greece)

^b General District Hospital of Agrini   (Greece)

^c AHEPA UNIVERSITY HOSPITAL   (Greece)

^d Xanthi General Hospital   (Greece)

^e Renal Unit   (Greece)

^f Ippokration Hospital Thessaloniki   (Greece)

^g Henri Dunant Hospital   (Greece)

^h Venizelion General Hospital   (Greece)

ⁱ Renal Unit   (Greece)

^j Hatzikosta Hospital   (Greece)

^k PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^l UNIVERSITY OF IOANNINA   (Greece)

^m Renal Unit   (Greece)

ⁿ Department of Medicine   (Greece)

^o LAIKO GENERAL HOSPITAL   (Greece)

^p Veterans' Hospital (NIMTS)   (Greece)

^q UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^r General Hospital of Volos   (Greece)

^s Renal Unit   (Greece)

^t Renal Unit   (Greece)

^u UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^v AMALIA FLEMING GENERAL HOSPITAL   (Greece)

more..

Author keywords

Darbepoetin alfa; Dialysis; Efficacy; Renal disease; rHuEPO; Safety; Tolerability

Indexed keywords

HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;

ADULT; AGED; ANEMIA; ANGINA PECTORIS; ARTICLE; BIOCHEMISTRY; BLEEDING; CHOLELITHIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FRACTURE; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEMATOLOGY; HUMAN; HYPERTENSION; INFLAMMATION; INSOMNIA; KIDNEY FAILURE; LABORATORY TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; OPEN STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STATISTICAL SIGNIFICANCE; THROMBOSIS; VASCULAR ACCESS; XEROSTOMIA;

EID: 27944508681     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2005.06.009     Document Type: Article

References (24)

1. National Renal Disease Patient Registry, Office for Coordination and Control of CRF, and Greek Ministry of Health and Welfare Bulletin of National Ministry of Health September 24, 2003
2. Krantz S.B. Erythropoietin Blood 77 1991 419 434
3. Lacombe C., and Mayeux P. Biology of erythropoietin Haematologica 83 1998 724 732
4. Caro J., Brown S., and Miller O. Erythropoietin levels in uremic, nephric and anephric patients J Lab Clin Med 93 1979 449 458
5. Eschbach J.W., Egrie J.C., and Downing M.R. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial N Engl J Med 316 1987 73 78
6. Joy M.S. Darbepoetin alfa: A novel erythropoiesis-stimulating protein Ann Pharmacother 36 2002 1183 1192
7. Overbay D.K., and Manley H.J. Darbepoetin alfa: A review of the literature Pharmacotherapy 22 2002 889 897
8. Macdougall I.C. Darbepoetin alfa: A new therapeutic agent for renal anemia Kidney Int Suppl 2002 55 61
9. Egrie J.C., and Browne J.K. Development and characterization of novel erythropoiesis stimulating protein (NESP) Nephrol Dial Transplant 16 Suppl 3 2001 3 13
10. Brunkhorst R., Bommer J., and Braun J. for the German Aranesp Study Group Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients Nephrol Dial Transplant 19 2004 1224 1230
11. Egrie J.C., Dwyer E., and Browne J.K. Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin Exp Hematol 31 2003 290 299
12. Locatelli F., Canaud B., and Giacardy F. Treatment of anemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant humanerythropoietin (rHuEpo) Nephrol Dial Transplant 18 2003 362 369
13. European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure Nephrol Dial Transplant 14 Suppl 5 1999 1 50
14. International Conference on Harmonisation: Guidelines for Good Clinical Practice April 26, 2005
15. Uehlinger D.E., Gotch F.A., and Sheiner L.B. A pharmacodynamic model of erythropoietin therapy for uremic anemia Clin Pharmacol Ther. 51 1992 76 89
16. NeoRocormon (epoetin beta) [European summary of product characteristics] 1997 Roche Diagnostics GmbH Penzberg, Germany
17. Eprex (epoetinum alfa) [European summary of product characteristics] 2003 Janssen Cilag Ltd Bucks, United Kingdom
18. Aranesp (darbepoetin alfa) [European summary of product characteristics] 2001 Amgen Europe BV Breda, the Netherlands
19. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative Am J Kidney Dis 30 Suppl 3 1997 S192 S240
20. Thiele A., and Wittner M. Improved haemoglobin concentrations with IV darbepoetin alfa-case studies of haemodialysis patients Curr Med Res Opin 18 2002 440 444
21. Jacobs C., Hörl W.H., and Macdougall I.C. European best practice guidelines 5: Target haemoglobin Nephrol Dial Transplant 15 Suppl 4 2000 15 19
22. Amgen Anaemia Advisory Group Darbepoetin alfa: A new erythropoietic drug for the treatment of renal anaemia Nephrology 7 2002 S173 S180
23. Nissenson A.R., Swan S.K., and Lindberg J.S. Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients Am J Kidney Dis 40 2002 110 118
24. Abstract Graf H., Lacombe J.L., and Braun J. Novel erythropoiesis stimulating protein (NESP) effectively maintains hemoglobin when administered at a reduced dose frequency compared with recombinant human erythropoietin (rHuEpo) in dialysis patients J Am Soc Nephrol 11 2000 A250